APPLICATION
ANDA200914
TYPE
ANDA
ORIGINAL APPROVAL
2011-12-13
LATEST ACTION
2020-10-13
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CYTARABINEDiscontinued
CYTARABINE 20MG/ML · INJECTABLE · INJECTION
Approval history
2020-10-13Labeling · Supplement 8 · standardAP
2015-01-16Labeling · Supplement 4 · standardAP
2015-01-16Labeling · Supplement 1 · standardAP
2011-12-13Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.